You are here: Industry Insights > discovery

News List

Mario Polywka Joins Orbit Discovery’s Board of Directors b3cnewswire
September 03, 2019
Orbit Discovery, an Oxford, UK-based biotech company developing an industry-leading peptide discovery platform, are pleased to announce that Dr Mario Polywka has joined their board as a non-executive director.
Recursion secures funds to support AI-based drug discovery pharmaceutical-technology
July 17, 2019
Artificial intelligence (AI) drug discovery firm Recursion Pharmaceuticals, has secured $121m in a series C funding round led by the Scottish Mortgage Investment Trust.
Bayer joins Sensyne Health consortium for accelerating new medicine discovery pharmatimes
May 10, 2019
Bayer joins Sensyne Health consortium for accelerating new medicine discovery.
Exscientia Launches New Subsidiary March 27, 2019
Exscientia K.K will spearhead the company's pharmaceutical interests across Asia.
Enamine, Lundbeck Extend Drug Discovery Pact contractpharma
March 27, 2019
Enamine will support Lundbeck’s in-house discovery chemistry competencies with three principal assets
BASi Appoints Key Executive contractpharma
March 08, 2019
Scott Daniels, PhD joins as senior vice president of DMPK, effective as of March 1, 2019
Novo Nordisk Purchases Berkeley Lights Beacon Platform contractpharma
December 13, 2018
Novo Nordisk has purchased Berkeley LightsBeacon Optofluidic platform to accelerate workflows in cell line development and to use the platform for future protein and antibody discovery.
InveniAI, Kyowa Hakko Kirin Partner for Drug Discovery contractpharma
December 12, 2018
InveniAI Corporation, a global leader in pioneering the application of artificial intelligence (AI) and machine learning (ML), has entered a collaboration agreement with Kyowa Hakko Kirin to use AI and ML for drug discovery.
Avacta, LG Chem Announce Collaboration contractpharma
December 12, 2018
Avacta Group and LG Chem Life Sciencesannounced a multi-target collaboration and development agreement. The agreement provides LG Chem with the exclusive rights to develop and commercialize, on a worldwide basis
Immunocore, Genentech Expand Anti-Cancer Alliance contractpharma
November 28, 2018
Immunocore Ltd., a T Cell Receptor (TCR) biotechnology company, has entered into a new partnership with Genentech, a member of the Roche Group, to expand an existing discovery

Previous page 1 2 Next page